SEP 19, 2019 8:00 AM PDT

Importance and Role of Biomarkers in the Management of Pediatric Inflammatory Disease

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Attending Physician, Pediatric Gastroenterology, Hepatology and Nutrition Co-Lead Investigator, Gi Care for Kids Site for ImproveCareNow, Quality Improvement Collaborative
    Biography
      Benjamin D. Gold, MD, joined Children's Center for Digestive Healthcare, LLC. GI Care for Kids, LLC. in 2009. Prior to joining CCDHC, Dr. Gold had an outstanding academic career at Emory University where he had been a Marcus Chair of Pediatric Gastroenterology, a tenured Professor of Pediatrics and Microbiology and the Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition.

      Dr. Gold is a national leader in the pursuit of critical questions regarding the epidemiology and pathobiology of acid-related diseases in children, in particular, gastroesophageal reflux disease (GERD) and other esophageal disease (i.e. Eosinophilic Esophagitis, EoE). He has been a key organizer and participant in all of the national and trans-Atlantic, clinical practice guidelines for treatment of pediatric H. pylori infection. In addition, 2005, he established the Aerodigestive Center of Children's Healthcare of Atlanta, and has been the Director of Quality for this multidisciplinary center that now follows almost 300 fragile, medically-complex children with Aerodigestive disease. He is the co-Director of GI Care for Kids site for the Improve Care Now Quality Improvement Collaborative which follows almost 1,100 children with IBD, and, is co-investigator on multiple national pediatric inflammatory bowel disease consortia as well as the evaluation of dietary approaches (i.e. specific carbohydrate diet; SCD) in the management of pediatric IBD. He was a member of the FDA panel establishing GRAS status for Lactobacillus and Bifidobacterium probiotics, and he has been actively involved in characterizing the gut microflora and its relationship to diet and the development and management of IBD, as well as GI allergy and eosinophilic esophagitis, EoE. Dr. Gold has diligently served the North American Society for Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN) in numerous capacities including being committee chair, being elected to counsel, and most recently, received the honor of being chosen by his peers in Canada, the U.S. and Mexico as the new President-elect of NASPGHAN.

      Dr. Gold has published over 155 peer-reviewed manuscripts, over 35 book chapters, is been a sought-after lecturer on upper GI disease in children, as well as, is an international thought leader on pediatric esophageal disease (gastroesophageal reflux disease, GERD; eosinophilic esophagitis, EoE), Helicobacter pylori infection, as well as gut-microbial interactions leading to intestinal inflammation, allergy and immune-mediate disease, including pediatric inflammatory bowel disease (Crohn's and ulcerative colitis).

    Abstract

    DATE: September 19, 2019
    TIME:  8:00am PDT, 11:00am EDT

    In this webinar we will be reviewing the role of host and the microbiome in the pathobiology of IBD and provide an overview of the epidemiology of the disease in pediatric patients and why phenotyping disease is important for therapy.  We will be discussing how the fecal microbiome is complex and biologically important, ie dysbiosis in a number of diseases, in particular IBD.  We will also be reviewing the diagnostic approach to the pediatric patient with suspected IBD and the methods for assessing treatment success including the importance of fecal calprotectin in diagnosis and monitoring outcomes.  Finally we will provide a brief overview of both the pharmacological and nutritional approach to pediatric IBD treatment.

    Learning Objectives:

    • Review basic immuno-pathobiology of IBD and the phenotypes of IBD or IBDs - Crohn’s, Ulcerative Colitis and Indeterminate Colitis
    • Briefly describe the epidemiology of IBD in children
    • Describe the diagnostic testing for IBD in the pediatric patient
    • Use of fecal biomarker(s), calprotectin for diagnosis and treatment monitoring
    • Outline approaches to treatment of IBD in children; and why these approaches might work, and why fecal calprotectin is an optimal tool to assess outcomes

     

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 19, 2019 8:00 AM PDT

    Importance and Role of Biomarkers in the Management of Pediatric Inflammatory Disease

    Sponsored by: DiaSorin
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Laboratory Testing

    Immunology

    Clinical Diagnostics

    Infectious Disease

    Molecular Diagnostics

    Molecular Biology

    Microbiology

    Diagnostics

    Clinical Chemistry

    Biomarkers

    Biochemistry

    Cell Biology

    Clinical Research

    Biotechnology

    Cancer Research

    Geography

    North America61%

    Europe18%

    Asia15%

    South America3%

    Oceania2%

    Africa1%

    Registration Source

    Website Visitors53%

    Email Promotions39%

    WAVE Newsletter Promotion5%

    Trending Newsletter Promotion1%

    Social Media Promotions1%

    Other1%

    Job Title

    Facility/Department Manager15%

    Medical Laboratory Technician15%

    Clinical Laboratory Scientist11%

    Lab Management9%

    Educator/Faculty9%

    Executive7%

    Student7%

    Research Scientist6%

    Medical Doctor/Specialist6%

    Scientist4%

    Chemist3%

    Pathologist2%

    Biologist2%

    Marketing/Sales1%

    Consultant1%

    QC/QA1%

    Organization

    Hospital24%

    Academic Institution16%

    Clinical Laboratory15%

    Biotech Company5%

    Medical Center4%

    Government4%

    Pharmaceutical Company3%

    Research Institute3%

    Medical Device Company3%

    Medical School3%

    Diagnostic Company2%

    Life Science Company2%

    Consultant2%

    Independent Laboratories2%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more